{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:39:52Z","timestamp":1758044392192,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"DOI":"10.7759\/cureus.92131","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:53:17Z","timestamp":1757677997000},"source":"Crossref","is-referenced-by-count":0,"title":["Idiopathic Parkinson\u2019s Disease Unmasked by Valproate-Induced Parkinsonism in a Patient With Vestibular Migraine"],"prefix":"10.7759","author":[{"given":"Teru","family":"Kamogashira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/wnf.0b013e31803bb3ee","article-title":"Effects of valproate on vestibular symptoms and electronystagmographic findings in migraine patients","volume":"30","author":"Celiker A","year":"2007","unstructured":"Celiker A, Bir LS, Ardi\u00e7 N. Effects of valproate on vestibular symptoms and electronystagmographic findings in migraine patients. Clin Neuropharmacol. 2007, 30:213-7. 10.1097\/wnf.0b013e31803bb3ee","journal-title":"Clin Neuropharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2011.09.002","article-title":"Valproic acid-induced Parkinsonism in the elderly: a comprehensive review of the literature","volume":"9","author":"Mahmoud F","year":"2011","unstructured":"Mahmoud F, Tampi RR. Valproic acid-induced Parkinsonism in the elderly: a comprehensive review of the literature. Am J Geriatr Pharmacother. 2011, 9:405-12. 10.1016\/j.amjopharm.2011.09.002","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8782","article-title":"Parkinsonism: a rare adverse effect of valproic acid","volume":"12","author":"Muralidharan A","year":"2020","unstructured":"Muralidharan A, Rahman J, Banerjee D, Hakim Mohammed AR, Malik BH. Parkinsonism: a rare adverse effect of valproic acid. Cureus. 2020, 12:e8782. 10.7759\/cureus.8782","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-931471","article-title":"Parkinsonism and\/or cognitive impairment with valproic acid therapy: a report of ten cases","volume":"39","author":"Masmoudi K","year":"2006","unstructured":"Masmoudi K, Gras-Champel V, Masson H, Andr\u00e9jak M. Parkinsonism and\/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry. 2006, 39:9-12. 10.1055\/s-2006-931471","journal-title":"Pharmacopsychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.03.016","article-title":"Valproic acid-induced Parkinsonism: levodopa responsiveness with dyskinesia","volume":"19","author":"Silver M","year":"2013","unstructured":"Silver M, Factor SA. Valproic acid-induced Parkinsonism: levodopa responsiveness with dyskinesia. Parkinsonism Relat Disord. 2013, 19:758-60. 10.1016\/j.parkreldis.2013.03.016","journal-title":"Parkinsonism Relat Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5080\/u12251","article-title":"Reversible valproic acid-induced Parkinsonism and cognitive impairment in an elderly patient with bipolar disorder I","volume":"27","author":"Hassamal S","year":"2016","unstructured":"Hassamal S, Waller S, Reese K, Testa C. Reversible valproic acid-induced Parkinsonism and cognitive impairment in an elderly patient with bipolar disorder I. Turk Psikiyatri Derg. 2016, 27:213-7. 10.5080\/u12251","journal-title":"Turk Psikiyatri Derg"},{"key":"ref7","article-title":"Clinical nystagmography. A detailed study of electro-nystagmography in 341 patients with vertigo","volume":"24","author":"Jongkees LB","year":"1962","unstructured":"Jongkees LB, Maas JP, Philipszoon AJ. Clinical nystagmography. A detailed study of electro-nystagmography in 341 patients with vertigo. Pract Otorhinolaryngol (Basel). 1962, 24:65-93.","journal-title":"Pract Otorhinolaryngol (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1990.01870040046011","article-title":"The development of the Dizziness Handicap Inventory","volume":"116","author":"Jacobson GP","year":"1990","unstructured":"Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990, 116:424-7. 10.1001\/archotol.1990.01870040046011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref9","article-title":"STAI Manual for the State-Trait Anxiety Inventory (\"Self-Evaluation Questionnaire\")","author":"Spielberger CD","year":"1970","unstructured":"Spielberger CD, Gorssuch RL, Lushene PR, Vagg PR, Jacobs GA. STAI Manual for the State-Trait Anxiety Inventory (\"Self-Evaluation Questionnaire\"). Consulting Psychologists Press, Palo Alto, CA; 1970."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A self-rating depression scale","volume":"12","author":"Zung WW","year":"1965","unstructured":"Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965, 12:63-70. 10.1001\/archpsyc.1965.01720310065008","journal-title":"Arch Gen Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen S","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983, 24:385-96. 10.2307\/2136404","journal-title":"J Health Soc Behav"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3233\/VES-2012-0453","article-title":"Vestibular migraine: diagnostic criteria","volume":"22","author":"Lempert T","year":"2012","unstructured":"Lempert T, Olesen J, Furman J, et al.. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012, 22:167-72. 10.3233\/VES-2012-0453","journal-title":"J Vestib Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000237539.09942.06","article-title":"Migrainous vertigo: prevalence and impact on quality of life","volume":"67","author":"Neuhauser HK","year":"2006","unstructured":"Neuhauser HK, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, Lempert T. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006, 67:1028-33. 10.1212\/01.wnl.0000237539.09942.06","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1756285611401647","article-title":"Management of vestibular migraine","volume":"4","author":"Bisdorff AR","year":"2011","unstructured":"Bisdorff AR. Management of vestibular migraine. Ther Adv Neurol Disord. 2011, 4:183-91. 10.1177\/1756285611401647","journal-title":"Ther Adv Neurol Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2014.00257","article-title":"Current treatment options in vestibular migraine","volume":"5","author":"Obermann M","year":"2014","unstructured":"Obermann M, Strupp M. Current treatment options in vestibular migraine. Front Neurol. 2014, 5:257. 10.3389\/fneur.2014.00257","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0341-8","article-title":"Valproate-associated Parkinsonism: a critical review of the literature","volume":"30","author":"Brugger F","year":"2016","unstructured":"Brugger F, Bhatia KP, Besag FM. Valproate-associated Parkinsonism: a critical review of the literature. CNS Drugs. 2016, 30:527-40. 10.1007\/s40263-016-0341-8","journal-title":"CNS Drugs"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.03.003","article-title":"Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease","volume":"17","author":"Hicks CW","year":"2011","unstructured":"Hicks CW, Pandya MM, Itin I, Fernandez HH. Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease. Parkinsonism Relat Disord. 2011, 17:379-81. 10.1016\/j.parkreldis.2011.03.003","journal-title":"Parkinsonism Relat Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6669-1","article-title":"Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease","volume":"260","author":"Sriram A","year":"2013","unstructured":"Sriram A, Ward HE, Hassan A, et al.. Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease. J Neurol. 2013, 260:521-7. 10.1007\/s00415-012-6669-1","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.47.3.626","article-title":"Reversible Parkinsonism and cognitive impairment with chronic valproate use","volume":"47","author":"Armon C","year":"1996","unstructured":"Armon C, Shin C, Miller P, Carwile S, Brown E, Edinger JD, Paul RG. Reversible Parkinsonism and cognitive impairment with chronic valproate use. Neurology. 1996, 47:626-35. 10.1212\/wnl.47.3.626","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-019-01239-8","article-title":"Valproate-induced rest tremor and Parkinsonism","volume":"121","author":"Baizabal-Carvallo JF","year":"2021","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M. Valproate-induced rest tremor and Parkinsonism. Acta Neurol Belg. 2021, 121:515-9. 10.1007\/s13760-019-01239-8","journal-title":"Acta Neurol Belg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21188","article-title":"Valproate-induced Parkinsonism in epilepsy patients","volume":"22","author":"Jamora D","year":"2007","unstructured":"Jamora D, Lim SH, Pan A, Tan L, Tan EK. Valproate-induced Parkinsonism in epilepsy patients. Mov Disord. 2007, 22:130-3. 10.1002\/mds.21188","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000121228.32913.00","article-title":"Reversible Parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate","volume":"62","author":"Easterford K","year":"2004","unstructured":"Easterford K, Clough P, Kellett M, Fallon K, Duncan S. Reversible Parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology. 2004, 62:1435-7. 10.1212\/01.wnl.0000121228.32913.00","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.073999","article-title":"Cardiac 123I-MIBG scintigraphy in patients with drug induced Parkinsonism","volume":"77","author":"Lee PH","year":"2006","unstructured":"Lee PH, Kim JS, Shin DH, Yoon SN, Huh K. Cardiac 123I-MIBG scintigraphy in patients with drug induced Parkinsonism. J Neurol Neurosurg Psychiatry. 2006, 77:372-4. 10.1136\/jnnp.2005.073999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/head.13815","article-title":"Parkinson's disease and headaches: a cross-sectional study","volume":"60","author":"Sampaio Rocha-Filho PA","year":"2020","unstructured":"Sampaio Rocha-Filho PA, Leite Souza-Lima CF. Parkinson's disease and headaches: a cross-sectional study. Headache. 2020, 60:967-73. 10.1111\/head.13815","journal-title":"Headache"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000840","article-title":"Midlife migraine and late-life Parkinsonism: AGES-Reykjavik study","volume":"83","author":"Scher AI","year":"2014","unstructured":"Scher AI, Ross GW, Sigurdsson S, et al.. Midlife migraine and late-life Parkinsonism: AGES-Reykjavik study. Neurology. 2014, 83:1246-52. 10.1212\/WNL.0000000000000840","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247354","article-title":"Drug-induced Parkinsonism: a strong predictor of idiopathic Parkinson's disease","volume":"16","author":"Jeong S","year":"2021","unstructured":"Jeong S, Cho H, Kim YJ, Ma HI, Jang S. Drug-induced Parkinsonism: a strong predictor of idiopathic Parkinson's disease. PLoS One. 2021, 16:e0247354. 10.1371\/journal.pone.0247354","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408948-idiopathic-parkinsons-disease-unmasked-by-valproate-induced-parkinsonism-in-a-patient-with-vestibular-migraine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:53:18Z","timestamp":1757677998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408948-idiopathic-parkinsons-disease-unmasked-by-valproate-induced-parkinsonism-in-a-patient-with-vestibular-migraine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.92131","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}